Updated Jakafi Labeling Approved by FDA

The FDA has approved supplemental labeling for Jakafi (ruxolitinib; Incyte) to include new Kaplan-Meier overall survival curves as well as additional safety and dosing information.

Interactions Important to Patients in Assessing Provider Quality

Most Americans focus on provider quality related to doctor-patient interactions rather than effectiveness of care when defining provider quality.

Touting Healthy Foods to Preschoolers May Backfire

Preschool children consume less food when it is presented as instrumental to achieving a health goal.

Post-Op Colorectal Recovery Program Aids Outcomes

Implementation of an enhanced recovery after surgery (ERAS) colorectal program is feasible in a community hospital setting and significantly improves outcomes.

RA Biologics Infection Risks Similar

The risk of hospitalized bacterial infections in older rheumatoid arthritis (RA) patients is similar for rituximab or abatacept compared to etanercept, although it is higher for infliximab.

Similar Burnout for Oncology Fellows, Clinicians Reported

U.S. oncology fellows may underestimate the workload they will experience once they enter practice, according to new research.